Colchicine, COVID-19 and hematological parameters: A meta-analysis

Colchicine, COVID-19 and hematological parameters: A meta-analysis

Introduction: Colchicine has the potential in reducing patient morbidity and mortality in COVID-19 infection owing to its anti-inflammatory properties. This study aims to determine the efficacy of colchicine in optimizing inflammatory hematological biomarker levels among COVID-19 patients. Methods:...

Full description

Bibliographic Details
Main Authors: Ali, Z. (Author), Cherrez-Ojeda, I. (Author), Fatima, M. (Author), Sarfraz, A. (Author), Sarfraz, Z. (Author), Sarwar, M. (Author)
Format: Article
Language:English
Published: John Wiley and Sons Inc 2021
Subjects:
antiinflammatory activity
Anti-Inflammatory Agents, Non-Steroidal
Article
biological marker
Biomarkers
blood
C reactive protein
colchicine
Colchicine
comparative study
coronavirus disease 2019
COVID-19
C-Reactive Protein
CRP
D dimer
D-dimer
disease severity
drug efficacy
drug therapy
fibrin degradation product
Fibrin Fibrinogen Degradation Products
fibrin fragment D
hematological parameters
human
Humans
laboratory test
lactate dehydrogenase
LDH
L-Lactate Dehydrogenase
meta analysis
mortality
nonsteroid antiinflammatory agent
patient monitoring
practice guideline
Severe acute respiratory syndrome coronavirus 2
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items